EUVIMEDEUVIMED entdecken
Crossref

Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients

C. Caze, G. Range, T. Bejan-Angoulvant, D. Angoulvant

Archives of Cardiovascular Diseases Supplements · 2018

DOI: 10.1016/j.acvdsp.2017.11.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Cardiovascular Diseases Supplements, 2018. Verfasst von C. Caze und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Caze, C., Range, G., Bejan-Angoulvant, T., & Angoulvant, D. (2018). Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients. Archives of Cardiovascular Diseases Supplements. https://doi.org/10.1016/j.acvdsp.2017.11.007

Vancouver

Caze C, Range G, Bejan-Angoulvant T, Angoulvant D. Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients. Archives of Cardiovascular Diseases Supplements. 2018. doi:10.1016/j.acvdsp.2017.11.007

BibTeX
@article{Caze2018,
  author = {Caze, C. and Range, G. and Bejan-Angoulvant, T. and Angoulvant, D.},
  title = {Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients},
  journal = {Archives of Cardiovascular Diseases Supplements},
  year = {2018},
  doi = {10.1016/j.acvdsp.2017.11.007}
}
Kostenlos starten →